Frank A. Holler, Director at Xenon Pharmaceuticals Inc. (XENE), sold 30,000 shares at $7.85 ($236K) on 2016-12-15, disclosed to the SEC on 2016-12-19.
Open-market sale of $236k XENE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| XENE | SELL | 2019-09-18 | $88K | — | Filing → |
| XENE | SELL | 2016-08-23 | $183K | — | Filing → |
| XENE | SELL | 2016-08-18 | $274K | — | Filing → |